- Home
- ALUR
as 01-17-2025 4:00pm EST
Stocks
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | NATICK |
| Market Cap: | 22.5M | IPO Year: | N/A |
| Target Price: | $75.00 | AVG Volume (30 days): | 87.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.37 - $98.75 | Next Earning Date: | 11-13-2024 |
| Revenue: | $34,754,000 | Revenue Growth: | -46.05% |
| Revenue Growth (this year): | -38.8% | Revenue Growth (next year): | 2.22% |
Latest Allurion Technologies Inc. News
ALUR Breaking Stock News: Dive into ALUR Ticker-Specific Updates for Smart Investing
Business Wire
4 days ago
Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024
Business Wire
10 days ago
Allurion Announces Positive Topline Results From AUDACITY Trial
Business Wire
25 days ago
Allurion Technologies, Inc. Announces Reverse Stock Split
Yahoo Finance
a month ago
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
Business Wire
2 months ago
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
Yahoo Finance
2 months ago
Allurion launches compounded GLP-1 program as FDA aims to end access
Business Wire
2 months ago
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
Simply Wall St.
2 months ago
Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83
Compare ALUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALUR Allurion Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.